XML 68 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule Of Share Based Compensation Shares Authorized Under Stock Plans Issued And Avaliability
(in thousands)
Common stock authorized11,000 
Stock-based awards, including restricted stock and stock options granted, net of expired or cancelled awards(6,379)
Common stock available for grant of stock-based awards as of December 31, 20234,621 
In addition, vested and unvested options to purchase 76 shares of common stock and 255 shares of unvested restricted stock awarded under the 2006 Plan were outstanding as of December 31, 2023.
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] The following weighted average assumptions were used for stock options granted during 2023, 2022, and 2021:
Years Ended December 31,
202320222021
Volatility
37.3% to 48.1%
42.5% to 51.1%
40.3% to 49.6%
Risk free interest rate
3.7% to 4.7%
1.2% to 3.0%
0.1% to 1.0%
Expected life in years
3.0 to 5.0
3.0 to 5.0
2.0 to 4.0
Dividend yield2.5%2.1%1.4%
Weighted average fair value$10.12$13.42$13.30
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
For the years ended December 31, 2023, 2022, and 2021, total equity-based compensation was as follows:
Years Ended December 31,
(in thousands)202320222021
Restricted stock$21,551 $21,005 $18,144 
Stock options2,597 3,391 4,134 
Total$24,148 $24,396 $22,278 
Schedule of cash proceeds and intrinsic values for stock options exercised table text block
Stock Options
Activity relating to stock options granted under the Company’s plans during the year ended December 31, 2023 was as follows:
(in thousands except for per share price)Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual TermAggregate Intrinsic Value
Outstanding at January 1, 20222,531 $29.06 
Granted276 $36.95 
Exercised(24)$25.61 
Forfeited(17)$39.28 
Outstanding at December 31, 20222,766 $29.82 2.0 years$11,778 
Vested and Exercisable at December 31, 20222,543 $29.11 1.8 years$11,741 
Outstanding at January 1, 20232,766 $29.82 
Granted237 30.74 
Exercised(1,654)25.14 
Expired(229)36.01 
Forfeited(2)46.28 
Outstanding at December 31, 20231,118 $35.62 3.2 years$7,684 
Vested and Exercisable at December 31, 2023935 $35.91 3.0 years$6,167 
At December 31, 2023, $1,336 of total unrecognized compensation cost related to non-vested stock option awards is expected to be recognized over a weighted-average period of 1.4 years.
Additional information pertaining to the Company's stock option plan was as follows:
Years Ended December 31,
(in thousands)202320222021
Cash received from the exercise of stock options$1,205 $602 $9,732 
Intrinsic value of stock options exercised$16,335 $314 $8,622 
Tax benefits realized on exercise of stock options$1,285 $41 $1,512